2017
DOI: 10.4103/iju.iju_328_16
|View full text |Cite
|
Sign up to set email alerts
|

Contrast-induced nephropathy in urological imaging: A comparison with cardiology interventions

Abstract: Introduction:Published studies about contrast-induced nephropathy (CIN) mainly focus on cardiac intervention and rarely focus on patients undergoing urological contrast investigations. We aimed to determine the association and effect of intravenous (IV) iodinated contrast material on the incidence of CIN in a group of patients undergoing urology investigation and compare the results with that of cardiology interventions.Methods:This prospective study was performed in patients undergoing IV contrast studies in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…Furthermore, MRA and CTA facilities are not available in all the hospitals, especially in the developing and least developed countries 26 . Angiography could also pose a risk to patients with kidney dysfunction and comorbidities, especially diabetes 27 , 28 . Angiography and CTA are invasive procedures that also require the injection of contrast materials and may not be suitable for patients who have had previous reactions to contrast agents, and MRA cannot be used in patients with metallic implants 29 , 30 .…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, MRA and CTA facilities are not available in all the hospitals, especially in the developing and least developed countries 26 . Angiography could also pose a risk to patients with kidney dysfunction and comorbidities, especially diabetes 27 , 28 . Angiography and CTA are invasive procedures that also require the injection of contrast materials and may not be suitable for patients who have had previous reactions to contrast agents, and MRA cannot be used in patients with metallic implants 29 , 30 .…”
Section: Discussionmentioning
confidence: 99%